ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 758423 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 758423; 2) Community: the network communities that were significantly associated with the response to NSC 758423; 3) Molecule: the relationships between components within communities and NSC 758423; 4) MDR: the compounds that were significantly associated with the NSC 758423.

NSC Compound Enrichment Correlation
NSC 740 Methotrexate 0.0108954273764103 0.43180261
NSC 748715 Null 0.0108954273764103 0.33877088
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0108954273764103 0.058260568
NSC 89074 Thiosulfuric acid (H2S2O3), -[2-[(5-cyclohexylpentyl)amino]ethyl] ester (9CI) 0.0108954273764103 0.057260339
NSC 143093 Acetylkidamycin 0.0138010872611484 0.40587174
NSC 1797 o-Aato-amidoazotoluol(German) 0.0138010872611484 0.51827645
NSC 266046 Oxaliplatin 0.0138010872611484 0.39259924
NSC 281279 Platinum, aqua(1,2-cyclohexanediamine-N,N')(tetraoxoselenato(2-)-O)-, (SP-4-3)- 0.0138010872611484 0.317614
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.0138010872611484 0.40174257
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.0138010872611484 0.44596694
Total:77  Current:25    [First] [Prev] [Next] [Last]